AR068536A1 - Vacuna antigripal inactivada - Google Patents
Vacuna antigripal inactivadaInfo
- Publication number
- AR068536A1 AR068536A1 ARP080104130A ARP080104130A AR068536A1 AR 068536 A1 AR068536 A1 AR 068536A1 AR P080104130 A ARP080104130 A AR P080104130A AR P080104130 A ARP080104130 A AR P080104130A AR 068536 A1 AR068536 A1 AR 068536A1
- Authority
- AR
- Argentina
- Prior art keywords
- inactivated
- vaccine
- influenza
- virus
- influenza virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
La presente se refiere a vacunas antigripales inactivadas y con adyuvantes. La presente brinda una vacuna que supera muchas de las desventajas de las vacunas antigripales inactivadas existentes. La presente brinda una vacuna antigripal inactivada, que comprende el virus de la influenza entero inactivado con beta propiolactona (BPL) y que comprende, como adyuvante, uno o más derivados de monosacáridos o disacáridos que tienen al menos uno pero no más de N-1 grupos éster de ácido graso y, opcionalmente, uno pero no más de N-1 grupos éster de sulfato, donde N es el numero de grupos hidroxilo del monosacárido o disacárido del cual se obtiene el derivado. El virus de la influenza en una vacuna de acuerdo con la presente se obtiene, preferentemente, de un cultivo celular. Los métodos para producir el virus de la influenza en un cultivo celular son conocidos en el arte. El virus se puede cultivar en células de origen mamífero, aviar; o humano, tales como células Madin Darby Canine Kidney (MDCK), Vero, MDBK, CLDK, EBx o PerC6.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97456807P | 2007-09-24 | 2007-09-24 | |
EP07117050 | 2007-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR068536A1 true AR068536A1 (es) | 2009-11-18 |
Family
ID=39590199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104130A AR068536A1 (es) | 2007-09-24 | 2008-09-24 | Vacuna antigripal inactivada |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2195020A1 (es) |
CN (1) | CN101808659A (es) |
AR (1) | AR068536A1 (es) |
BR (1) | BRPI0817230A2 (es) |
TW (1) | TW200927928A (es) |
WO (1) | WO2009040343A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9278999B2 (en) | 2012-01-27 | 2016-03-08 | Newport Laboratories | Influenza C virus and vaccine |
CA2954740C (en) | 2014-07-11 | 2022-10-18 | National Research Council Of Canada | Sulfated-glycolipids as adjuvants for vaccines |
CN104792985A (zh) * | 2015-04-21 | 2015-07-22 | 乾元浩生物股份有限公司 | 定性定量分析禽用禽流感病毒抗原有效成分的方法 |
EP3684406A4 (en) * | 2017-09-07 | 2021-08-11 | Hawaii Biotech, Inc. | FILOVIRUS VACCINES AND METHOD OF USE |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1104767A1 (en) * | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
NZ594482A (en) * | 2005-11-04 | 2012-11-30 | Novartis Vaccines & Diagnostic | Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant |
-
2008
- 2008-09-19 TW TW097136110A patent/TW200927928A/zh unknown
- 2008-09-23 BR BRPI0817230A patent/BRPI0817230A2/pt not_active IP Right Cessation
- 2008-09-23 CN CN200880108502A patent/CN101808659A/zh active Pending
- 2008-09-23 EP EP08804610A patent/EP2195020A1/en not_active Withdrawn
- 2008-09-23 WO PCT/EP2008/062694 patent/WO2009040343A1/en active Application Filing
- 2008-09-24 AR ARP080104130A patent/AR068536A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN101808659A (zh) | 2010-08-18 |
WO2009040343A1 (en) | 2009-04-02 |
BRPI0817230A2 (pt) | 2017-06-06 |
EP2195020A1 (en) | 2010-06-16 |
TW200927928A (en) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013022397A2 (pt) | vacinas combinadas com doses menores de antígeno e/ou adjuvante | |
BR112018012873A2 (pt) | vacina de vírus zika | |
BR112018008102A2 (pt) | vacina de vírus sincicial respiratório | |
CO2017011245A2 (es) | Conjugados proteína-polisacárido de estreptococo grupo b, métodos para producir conjugados, composiciones inmunógenas que comprenden conjugados y sus usos | |
CL2016003048A1 (es) | Analogos de panonina minimas sintesis y uso de los mismos. | |
BR112018008090A2 (pt) | vacina de vírus do herpes simplex. | |
BR112018008078A2 (pt) | vacina de vírus influenza de amplo espectro | |
BR112013029834A8 (pt) | vacinas individualizadas para câncer | |
BR112012004698A2 (pt) | métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada. | |
BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
BRPI0918806A2 (pt) | composição compreendendo quitosana para administração ocular de vaninas em aves | |
AR073959A1 (es) | Vacuna de combinacion con tos ferina acelular y metodo para su elaboracion | |
BR112015018270A2 (pt) | composições que compreendem 15-ohepa e métodos de uso das mesmas | |
BR112018010503A2 (pt) | ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave | |
UY33297A (es) | Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas | |
AR068536A1 (es) | Vacuna antigripal inactivada | |
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
BR112015005056A2 (pt) | vacinas de combinação com sorogrupo b meningococcus e d/t/p | |
BR112012030659B8 (pt) | Parvovírus vivo atenuado, vacinas que o compreendem e método para a fabricação das referidas vacinas | |
CO2017007057A2 (es) | Vacuna contra la fiebre aftosa | |
BR112016030294A8 (pt) | cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas | |
BR112019009131A2 (pt) | vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas | |
CU24579B1 (es) | Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue | |
BR112017004746A2 (pt) | métodos para preparação de virossomas adjuvados, para otimizar a proporção adjuvante/antígeno de uma vacina à base de virossoma e para imunizar um indivíduo contra uma doença, virossoma adjuvado, composição farmacêutica, e, composição imunogênica. | |
BR112013006515B1 (pt) | vacina de combinação, e, método para a fabricação de uma vacina de combinação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |